OTCQB:VVCIF - Post by User
Post by
1hot-techwomanon Apr 12, 2018 1:00pm
100 Views
Post# 27874281
Sales of cannibus products expected to rise ;)
Sales of cannibus products expected to rise ;)Sales of Medical and Recreational Cannabis Products Are Projected Rise Thursday, April 12, 2018, 12:46 PM ET FinancialBuzz.com News Commentary NEW YORK, April 12, 2018 /PRNewswire/ -- According to a report by Energias Market Research, the global medical cannabis market is anticipated to grow significantly from USD 8.28 billion in 2017 to USD 28.07 billion in 2024, at a CAGR of 19.1% from 2018 to 2024. Factors driving the advances of the medical cannabis market include increasing recognition of medical benefits, stronger demand for cannabis in the treatment of various diseases, and rising number of research and development activities. Sales of cannabis products for recreational use are also expected to increase, as California's new recreational cannabis laws went into effect on January 1st, 2018. While California is the largest market, Canada is projected to show strong sales as well. Deloitte's report projects the Canadian market will be worth at least $5B in sales in 2018. Body and Mind Inc. (OTC: BMMJ), Cannabis Sativa, Inc. (OTC: CBDS), AXIM Biotechnologies, Inc. (OTC: AXIM), Emblem Corp. (OTC: EMMBF), Namaste Technologies Inc. (OTC: NXTTF)